-
1
-
-
34548436461
-
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris
-
Schlessinger J, Menter A, Gold M, et al. Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. J Drugs Dermatol. 2007;6:607-615.
-
(2007)
J Drugs Dermatol
, vol.6
, pp. 607-615
-
-
Schlessinger, J.1
Menter, A.2
Gold, M.3
-
2
-
-
37049033269
-
Safety of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: Results from a 52-week open-label study
-
Poster presented at: March 3-9, Maui, HI
-
Leyden JJ, Wortzman M, Plott T. Safety of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: results from a 52-week open-label study. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
-
(2007)
31st Hawaii Dermatology Seminar
-
-
Leyden, J.J.1
Wortzman, M.2
Plott, T.3
-
3
-
-
37049032120
-
A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: Efficacy in patients with mild, moderate, and severe baseline acne
-
Poster presented at: March 3-9, Maui, HI
-
Leyden JJ, Plott T, Wortzman M. A novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate: efficacy in patients with mild, moderate, and severe baseline acne. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
-
(2007)
31st Hawaii Dermatology Seminar
-
-
Leyden, J.J.1
Plott, T.2
Wortzman, M.3
-
4
-
-
44649108644
-
Unique aqueous formulation results in reduced risk of tretinoin-induced irritation bioassay
-
Poster presented at: March 3-9, Maui, HI
-
Plott RT. Unique aqueous formulation results in reduced risk of tretinoin-induced irritation bioassay. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
-
(2007)
31st Hawaii Dermatology Seminar
-
-
Plott, R.T.1
-
5
-
-
33646741602
-
Evaluation of a patented pad formulation of benzoyl peroxide in combination with a topical retinoid: Chemical stability, efficacy, and tolerability
-
Del Rosso JQ. Evaluation of a patented pad formulation of benzoyl peroxide in combination with a topical retinoid: chemical stability, efficacy, and tolerability. Cosmet Dermatol. 2006;19:93-97.
-
(2006)
Cosmet Dermatol
, vol.19
, pp. 93-97
-
-
Del Rosso, J.Q.1
-
6
-
-
44649104827
-
Clindamycin phosphate 1.2%/tretinoin 0.025% gel: Vehicle characteristics, stability and tolerability
-
Poster presented at: October 18-21, Las Vegas, NV
-
Del Rosso JQ, Bhambri S, Momin S. Clindamycin phosphate 1.2%/tretinoin 0.025% gel: vehicle characteristics, stability and tolerability. Poster presented at: Fall Clinical Dermatology Conference; October 18-21, 2007; Las Vegas, NV.
-
(2007)
Fall Clinical Dermatology Conference
-
-
Del Rosso, J.Q.1
Bhambri, S.2
Momin, S.3
-
7
-
-
44649115517
-
-
Data on file. Scottsdale, AZ: Medicis Pharmaceutical Corporation; 2007.
-
Data on file. Scottsdale, AZ: Medicis Pharmaceutical Corporation; 2007.
-
-
-
-
8
-
-
37049032120
-
A novel gel formulation of tretinoin and clindamycin is not associated with retinoid induced flaring of inflammatory acne
-
Poster presented at: March 3-9, Maui, HI
-
Leyden JJ, Plott T, Wortzman M. A novel gel formulation of tretinoin and clindamycin is not associated with retinoid induced flaring of inflammatory acne. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
-
(2007)
31st Hawaii Dermatology Seminar
-
-
Leyden, J.J.1
Plott, T.2
Wortzman, M.3
-
9
-
-
44649138299
-
Comparison of facial tolerance of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate, 0.1% adapalene gel, and 0.1% tretinoin microsphere gel
-
Poster presented at: March 3-9, Maui, HI
-
Leyden JJ, Plott T, Wortzman M. Comparison of facial tolerance of a novel gel formulation of 0.025% tretinoin and 1.2% clindamycin phosphate, 0.1% adapalene gel, and 0.1% tretinoin microsphere gel. Poster presented at: 31st Hawaii Dermatology Seminar; March 3-9, 2007; Maui, HI.
-
(2007)
31st Hawaii Dermatology Seminar
-
-
Leyden, J.J.1
Plott, T.2
Wortzman, M.3
|